Sort
11,323 grants matching “glioblastoma”
Studying a novel regulator of GBM tumorigeneis: the role of CK2alpha in maintaini
$179,664Gordon Li · Stanford University · K08 · FY2015 · NS
A novel strategy to overcome resistance in Temozolomide-Refractory Glioblastomas
$179,619Paul Hergenrother · University Of Illinois At Urbana-Champaign · R21 · FY2015 · CA
Functions of Cyclin/CDK complexes in development and cancer
$179,618Yan Geng · Dana-Farber Cancer Inst · R50 · FY2019 · CA
Functions of Cyclin/CDK complexes in development and cancer
$179,618Yan Geng · Dana-Farber Cancer Inst · R50 · FY2021 · CA
Functions of Cyclin/CDK complexes in development and cancer
$179,618Yan Geng · Dana-Farber Cancer Inst · R50 · FY2020 · CA
Functions of Cyclin/CDK complexes in development and cancer
$179,618Yan Geng · Dana-Farber Cancer Inst · R50 · FY2023 · CA
Functions of Cyclin/CDK complexes in development and cancer
$179,618Yan Geng · Dana-Farber Cancer Inst · R50 · FY2022 · CA
BRAIN TUMOR BIOREPOSITORY, HISTOPATHOLOGY, AND IMMUNOLOGIC MONITORING
$179,614Roger E McLendon · Duke University · P50 · FY2011 · NS
The Role of Eph-ephrin Interactions in Glioma Migration
$179,575Peter D Canoll · Columbia University Health Sciences · K08 · FY2007 · NS
Role of Nuclear Factor I A (NFIA) gene in glioma
$179,571Hae-Ri Song · New York University School Of Medicine · K08 · FY2012 · NS
Development of Quantitative Deuterium MRS Imaging for Human Brain Tumor Application at Ultrahigh Field
$179,567Wei Chen · University Of Minnesota · R01 · FY2021 · CA
Targeted electric field therapy for malignant infiltrative glioma
$179,426Scott S Verbridge · Virginia Polytechnic Inst And St Univ · R21 · FY2015 · CA
A Phase 2 biomarker driven, Study of DB107, a Retroviral Replicating Vector, Combined With 5-FC in Patients with Recurrent Glioblastoma or Anaplastic Astrocytoma
$179,403Ashish Harish Shah · University Of Miami School Of Medicine · R21 · FY2023 · CA
Evaluation of impact of anti-VEGF drugs on concomitant chemotherapy in GBM
$179,280Elizabeth Gerstner · Massachusetts General Hospital · K23 · FY2016 · CA
Evaluation of impact of anti-VEGF drugs on concomitant chemotherapy in GBM
$179,280Elizabeth Gerstner · Massachusetts General Hospital · K23 · FY2015 · CA
Evaluation of impact of anti-VEGF drugs on concomitant chemotherapy in GBM
$179,280Elizabeth Gerstner · Massachusetts General Hospital · K23 · FY2018 · CA
Evaluation of impact of anti-VEGF drugs on concomitant chemotherapy in GBM
$179,280Elizabeth Gerstner · Massachusetts General Hospital · K23 · FY2014 · CA
Evaluation of impact of anti-VEGF drugs on concomitant chemotherapy in GBM
$179,280Elizabeth Gerstner · Massachusetts General Hospital · K23 · FY2017 · CA
Mutagenesis and migration in glioblastoma cells
$179,240Eun Hyun Ahn · University Of Washington · R21 · FY2018 · CA
Genetic Mouse Models of Glioma
$179,173Luis F Parada · Ut Southwestern Medical Center · R01 · FY2015 · CA
Multifunctional, GBM-activatable nanocarriers for image-guided photochemotherapy
$179,122Huang Chiao Huang · Massachusetts General Hospital · K99 · FY2016 · CA
Multifunctional, GBM-activatable nanocarriers for image-guided photochemotherapy
$179,035Huang Chiao Huang · Massachusetts General Hospital · K99 · FY2017 · CA
Multiphoton Fluorescence Lifetime Imaging of Solid Tumors Invivo
$178,750V.krishnan Ramanujan · Cedars-Sinai Medical Center · R21 · FY2010 · CA
Combined Pre & Intraoperative Brain Tumor Imaging Strategy using a Dual-Modality
$178,740Moritz Florian Kircher · Sloan-Kettering Inst Can Research · K08 · FY2014 · CA
Combined Pre & Intraoperative Brain Tumor Imaging Strategy using a Dual-Modality
$178,740Moritz Florian Kircher · Sloan-Kettering Inst Can Research · K08 · FY2012 · CA